Good contribution to the discussion. My understanding is that bgd is well place to face the changes as most of its revenue comes from gp services and pathology subleases make up small % of their revenue. Would you share this view?
- Forums
- ASX - By Stock
- BGD
- Prediction for the re-listing
Prediction for the re-listing, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)